{"result": {"id": "133a0e70-4009-4afa-a069-a7bf59b3e4d2", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>NOAC<|>ORGANIZATION<|>Non-vitamin K antagonist oral anticoagulants used in clinical trials for non-valvular atrial fibrillation patients, compared with warfarin in preventing stroke and systemic embolism, with fewer or similar bleeding complications.\")\n##\n(\"entity\"<|>INR<|>ORGANIZATION<|>International Normalized Ratio used to guide warfarin therapy, with a target range of 2.0-3.0.\")\n##\n(\"entity\"<|>RAS INHIBITOR<|>ORGANIZATION<|>Recommended for high-risk hypertensive patients with left atrial enlargement, LVH, or reduced cardiac function to reduce atrial fibrillation occurrence.\")\n##\n(\"entity\"<|>β RECEPTOR BLOCKER<|>ORGANIZATION<|>First-line medication for hypertensive patients with increased heart rate.\")\n##\n(\"relationship\"<|>NOAC<|>WARFARIN<|>NOACs were compared with warfarin in clinical trials for non-valvular atrial fibrillation patients.<|>7\")\n##\n(\"relationship\"<|>RAS INHIBITOR<|>ATRIAL FIBRILLATION<|>RAS inhibitors are recommended to reduce atrial fibrillation occurrence in high-risk hypertensive patients.<|>6\")\n##\n(\"relationship\"<|>β RECEPTOR BLOCKER<|>HYPERTENSION<|>β receptor blockers are the first-line treatment for hypertensive patients with increased heart rate.<|>8\")\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558662, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 325, "prompt_tokens": 2471, "total_tokens": 2796, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 679}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �� 。将三方面的治疗措施进行整体结构化管理 ,是 房颤治疗理念最近的趋势。\n凡是具有血栓栓塞危险因素的高血压合并房颤患\n\n\n　者 ,应按照现行指南进行抗凝治疗[360] 。非维生素 K  拮抗类口服抗凝药(non-vitaminK antagonistoralan- ticoagulants,NOAC)[361-364] 在非瓣膜病房颤患者的临  床试验中与华法林进行了比较 ,预防脑卒中和体循环  栓塞方面取得了非劣效或优效的结果 , 出血并发症不  多于或少于华法林 ,所有药物均明显减少颅内出血。 建议根据适应证和禁忌证优先使用 , 给予正确药物种  类及 剂 量 , 规 范 进 行 随 访[365] 。 在 无 或 不 能 使 用  NOAC的情况下可以在国际标准化比值(internation- alnormalized ratio,INR) 指导下使用华法林 ,将 INR 控制在 2.0~ 3.0。 由于我国人群华法林代谢基因特  点 ,在初始或调整华法林治疗剂量时应给予特别考虑  和注意 , 以保证疗效并避免出血不良反应。\n　　有症状的房颤患者 ,应按现行指南进行室率或节 律控制[360]  , 以改善症状 ,提高患者的生活质量 。根据 最新的研究结果 ,对有脑卒中危险因素的新近房颤患 者(1年内)应积极使用射频消融或抗心律失常药物进 行节律控制 ,可改善患者的预后[366] 。\n　　　多种疾病和危险因素与房颤有关 ,应按照当今各 项指南进行治疗 。合并房颤的高血压患者应进行血压 控制 ,并力争达标 。高血压易致房颤的高危患者如合 并左房增大、LVH、心功能降低 ,推荐使用 RAS抑制 剂以减少房颤的发生[360] 。但目前没有证实此类药物 可以用于已有房颤患者的二级预防来减少房颤负荷。\n　　合并房颤的患者可使用已在房颤患者中进行过准 确性验证的电子血压计 ,也可使用水银血压计进行血 压测量 。无论使用哪一种血压计 ,都建议采用多次血 压测量取平均值。\n5.3.5  心率控制\n\n要点 5L  心率控制\n　　　·所有高血压患者在测量血压的同时应测量静 息心率( Ⅰ ,C) 。\n　　　· 高血压患者心率增快的定义为诊室静息心 率>80次/min( Ⅱa,C) 。\n　　　· 高血压患者心率增快时应排查诱因和原因 ( Ⅰ ,C) 。\n　　　·高血压伴心率增快患者的药物治疗首选 β受 体阻滞剂( Ⅰ ,C) 。\n\n　　静息心率增快很可能是独立的心血管危险因素。 多个国家的高血压指南或共识将心率增快定义为 >  80次/min,建议高血压患者将静息心率控制在 60~  80次/min[108,129\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_1f4e98058e08d56b394ce7d5549195160bab1b39f486444e9765b50190712bd3_v2"}